By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Goldman Sachs today lowered estimates for Illumina following last week's pre-announcement of third-quarter revenues that fall short of Wall Street expectations.

In a research note, analyst Isaac Ro lowered estimates for 2012 through 2014 "as we take a more cautious view on HiSeq placements … consumable pull-through, MiSeq placements, and array growth."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Feb
21
Sponsored by
Oracle Health Sciences

This webinar will cover best practices for integrating data from multiple clinical and genomic sources for clinical decision support.